Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine dose and pharmacokinetics in gout patients with renal impairment
TCTR20220322010Completed
- Sponsor
- Naresuan University
- Start
- Jul 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of colchicine in gout, sponsored by Naresuan University. Primary endpoint: Colchicine pharmacokinetic parameters. Started Jul 2022; status: completed.
02
Drugs
colchicine
03
Conditions
gout
Beyond the preview
Go deeper on TCTR20220322010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220322010.